Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5220
Title: Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review
Authors: Younan, Romy G
Raad, Roy A
Sawan, Bassem Y
Said, Rabih
Affiliations: Faculty of Medicine 
Faculty of Medicine 
Faculty of Medicine 
Keywords: ATG
Anti-Thymocyte Globulin
Cyclosporine
Eltrombopag
Ipilimumab
Nivolumab
Issue Date: 2021
Publisher: BMC
Part of: Allergy, Asthma & Clinical Immunology
Volume: 17
Issue: 1
Start page: 1
End page: 5
Abstract: 
Treatment with immune checkpoint inhibitors has revolutionized cancer treatment over the past several years. Despite their clinical benefits, a wide range of immune-mediated toxicities can be observed including hematological toxicities. Although, the majority can easily be managed, immune-mediated adverse events rarely can be severe and difficult to approach. Herein, we are reporting a case of very severe aplastic anemia secondary to ipilimumab (I) and nivolumab (N) treatment that failed various treatment including intensive immune suppressive therapy.
URI: https://scholarhub.balamand.edu.lb/handle/uob/5220
ISSN: 1710-1484
DOI: 10.1186/s13223-021-00616-4
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Record view(s)

4
checked on Jan 23, 2022

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.